ARV Supply Expected To Stabilise As Court Battle Ends

Monday, November 18, 2019

The supply of Anti Retroviral (ARV) drugs is expected to stabilise after government won a marathon court battle against one of the major suppliers, Portfolio Pharmaceuticals.

The company had cited irregularities in awarding of a tender for the supply of the drugs, after Portfolio Pharmaceuticals lost a significant share of the market to other players.

Following that, a lengthy court battle ensued, which had affected supply, with some patients receiving a weekly, rather than their monthly allocations.

Already have an active account? Log in here.

Or Sign up and get unlimited access to premium articles.

Neighbour arrested for allegedly raping a 13-year-old girl

Pini Bothoko | 4 h ago

Motswana receives Wayfinder award

Staff Writer | 6 h ago

Grand Palm rekindle 70s, 80s disco tonight

Staff Writer | 6 h ago

Three battle to break into top eight

Larona Makhaiza | 7 h ago

Top cyclists miss out on Olympic qualifiers

Calistus Kolantsho | 8 h ago

Seven heads of state for US, Africa Business Summit

Mbongeni Mguni | 23 h ago

GBV: The big elephant in the room

Sadly, the country seems not to have proper tools and the extent to which women and the girl-child are being abused is not adequately measured.Almost every week there are reports of women being attacked by their significant others and while men are attacked as well, women seem to be more on the receiving end.On May 24, 2023 news broke that a woman who was receiving support from the Botswana Gender-Based Violence Prevention Centre in Gaborone, was...

The Monitor Editor | 29 May 2023

About us

Mmegi is the leading independent source of breaking news, latest news, current
affairs, Politics, Business, Sport, debates, analysis, and entertainment news in Botswana.

Explore

More